AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Marzetti, you need to believe its brands, licensing deals, and product innovation can offset slow category growth and margin pressure from retailers and input costs. The key short term catalyst is improved supply chain productivity, and Mark Carter’s appointment looks supportive but not transformational by itself. The biggest risk remains that shifting consumer preferences toward fresher, cleaner labels and private label pressure could chip away at volumes and pricing power if innovation and execution lag.
The most relevant recent announcement alongside Carter’s hiring is Marzetti’s continued supply chain optimization, highlighted in its latest results and share buyback disclosure. Management has been closing higher cost facilities and ramping newer plants to support margin improvement. Carter’s deep experience running large manufacturing networks may help sustain these productivity gains, which matter for how effectively Marzetti can reinvest in new products and marketing while managing the risk of rising input cost volatility.
But while Carter’s hire looks positive, investors should be aware that input cost swings and retailer bargaining power could still...
Read the full narrative on Marzetti (it's free!)
Marzetti's narrative projects $2.1 billion revenue and $214.0 million earnings by 2029. This requires 2.7% yearly revenue growth and about a $38.5 million earnings increase from $175.5 million today.
Uncover how Marzetti's forecasts yield a $159.40 fair value, a 39% upside to its current price.
Compared with the consensus view, the most pessimistic analysts already saw more modest upside, assuming revenue of about US$2.1 billion and earnings near US$214 million by 2029, and they focus more on how heavy capital spending and complex projects such as facility upgrades might blunt margin gains if execution slips. In light of Carter’s appointment, it is worth asking whether those more cautious expectations on profitability and integration risk will still hold, or if the supply chain story could shift.
Explore 2 other fair value estimates on Marzetti - why the stock might be worth 35% less than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com